Recap: Panbela Therapeutics Q4 Earnings
Recap: Panbela Therapeutics Q4 Earnings
Panbela Therapeutics (OTC:PBLA) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:10 PM.
Panbela Therapeutics（場外交易代碼：PBLA）於2024年3月26日星期二下午4點10分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Panbela Therapeutics missed estimated earnings by -171.0%, reporting an EPS of $-65.9 versus an estimate of $-24.34.
Panbela Therapeutics報告每股收益爲-65.9美元，未達到預期收益-171.0％，而預期爲-24.34美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company missed on EPS by $0.36 which was followed by a 3.0% increase in the share price the next day.
上個季度，該公司的每股收益未達到0.36美元，隨後第二天股價上漲了3.0％。
To track all earnings releases for Panbela Therapeutics visit their earnings calendar here.
要追蹤Panbela Therapeutics發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。